SCHEMBL1097663

SCHEMBL1097663

CC(=O)c1c(N(Cc2ccccc2)S(=O)(=O)c2ccc(Br)cc2)sc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.49
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
GAA P10253 2/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
ESR1 P03372 1/20 0.42
MMP9 P14780 4/20 0.41
MMP1 P03956 3/20 0.41
MMP13 P45452 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TAS2R14 Q9NYV8 2/20 0.41
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
NPC1 O15118 1/20 0.40
PTPN22 Q9Y2R2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1100024 0.92 TRPM8 (0.49) TRPM8KEAP1NFE2L2MAPTKMT2A
SCHEMBL1098796 0.87 TRPM8 (0.66) TRPM8KEAP1NFE2L2
SCHEMBL1099631 0.85 TRPM8 (0.51) TRPM8KEAP1NFE2L2GAAHTT
SCHEMBL1099606 0.84 ESR1 (0.44) TRPM8KEAP1NFE2L2GAAHTT
SCHEMBL1098629 0.84 TRPM8 (0.67) TRPM8MMP9MMP1MMP13
SCHEMBL1100267 0.82 TRPM8 (0.49) TRPM8KEAP1NFE2L2GAAHTT
SCHEMBL1097642 0.81 TRPM8 (0.56) TRPM8GAAMAPTMEN1KMT2A
SCHEMBL1099819 0.80 TRPM8 (0.40) TRPM8KEAP1NFE2L2HTTMAPT
SCHEMBL1098790 0.78 TRPM8 (0.47) TRPM8KEAP1NFE2L2GAAHTT
SCHEMBL1099575 0.77 TRPM8 (0.71) TRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
CN-101801949-B Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2014-09-24 CN disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.